| Product Code: ETC7747314 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Japan's import shipments of remdesivir in 2024 continued to be sourced primarily from top exporting countries such as the USA, Germany, Ireland, Switzerland, and Sweden. Despite this, the market remains characterized by low concentration as indicated by the Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 was -3.23%, with a slight improvement in the growth rate from 2023 to 2024 at -2.99%. This data suggests a stable yet slightly declining trend in the importation of remdesivir into Japan.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Remdesivir Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Remdesivir Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Remdesivir Market - Industry Life Cycle |
3.4 Japan Remdesivir Market - Porter's Five Forces |
3.5 Japan Remdesivir Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
3.6 Japan Remdesivir Market Revenues & Volume Share, By Form, 2021 & 2031F |
4 Japan Remdesivir Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Japan |
4.2.2 Growing awareness about the effectiveness of remdesivir in treating viral infections |
4.2.3 Government support and funding for healthcare infrastructure and research in Japan |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Japan |
4.3.2 Competition from other antiviral drugs in the market |
4.3.3 Potential side effects and safety concerns associated with remdesivir |
5 Japan Remdesivir Market Trends |
6 Japan Remdesivir Market, By Types |
6.1 Japan Remdesivir Market, By Patient Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Remdesivir Market Revenues & Volume, By Patient Type, 2021- 2031F |
6.1.3 Japan Remdesivir Market Revenues & Volume, By Adult, 2021- 2031F |
6.1.4 Japan Remdesivir Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.1.5 Japan Remdesivir Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.2 Japan Remdesivir Market, By Form |
6.2.1 Overview and Analysis |
6.2.2 Japan Remdesivir Market Revenues & Volume, By Lyophilized Powder, 2021- 2031F |
6.2.3 Japan Remdesivir Market Revenues & Volume, By Concentrated Solution, 2021- 2031F |
7 Japan Remdesivir Market Import-Export Trade Statistics |
7.1 Japan Remdesivir Market Export to Major Countries |
7.2 Japan Remdesivir Market Imports from Major Countries |
8 Japan Remdesivir Market Key Performance Indicators |
8.1 Number of clinical trials conducted on remdesivir in Japan |
8.2 Adoption rate of remdesivir in Japanese hospitals and healthcare facilities |
8.3 Patient satisfaction and outcomes data related to remdesivir treatment in Japan |
9 Japan Remdesivir Market - Opportunity Assessment |
9.1 Japan Remdesivir Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
9.2 Japan Remdesivir Market Opportunity Assessment, By Form, 2021 & 2031F |
10 Japan Remdesivir Market - Competitive Landscape |
10.1 Japan Remdesivir Market Revenue Share, By Companies, 2024 |
10.2 Japan Remdesivir Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |